These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 494938)

  • 41. [Slowly progressing schizophrenia with exacerbations during the involutional period].
    Rostovskiĭ EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(5):107-13. PubMed ID: 7102187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in the clinical picture and course of psychoses as a result of massive psychopharmacotherapy and their role in improving treatment services].
    Avrutskiĭ GIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(9):1387-94. PubMed ID: 40371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paranoid symptoms in patients on a general hospital psychiatric unit. Implications for diagnosis and treatment.
    Freedman R; Schwab PJ
    Arch Gen Psychiatry; 1978 Mar; 35(3):387-90. PubMed ID: 727891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The paranoid syndrome.
    Manschreck TC; Petri M
    Lancet; 1978 Jul; 2(8083):251-3. PubMed ID: 79043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current pharmacologic therapy of depressive psychoses in the involutional period of human life].
    Ristić J; Milovanović D; Ilić A; Poleksić J; Stojiljković S
    Med Glas; 1971 Oct; 25(10):352-7. PubMed ID: 5148043
    [No Abstract]   [Full Text] [Related]  

  • 46. Manic-depressive illness and paranoid schizophrenia. A phenomenologic, family history, and treatment-response study.
    Abrams R; Taylor MA; Gaztanaga P
    Arch Gen Psychiatry; 1974 Nov; 31(5):640-2. PubMed ID: 4441237
    [No Abstract]   [Full Text] [Related]  

  • 47. [EXPERIENCE WITH THE TREATMENT OF PATHOLOGIC CLIMACTERIUM WITH PSYCHOTROPIC DRUGS AND THE PREVENTION OF INVOLUTIONAL PSYCHOSES].
    VOLF MSh
    Sov Med; 1964 Sep; 28():107-10. PubMed ID: 14257225
    [No Abstract]   [Full Text] [Related]  

  • 48. [Schizophrenic "terminal stages". Clinic and course].
    Marinow A
    Arch Psychiatr Nervenkr (1970); 1971; 215(1):46-61. PubMed ID: 5157710
    [No Abstract]   [Full Text] [Related]  

  • 49. Involutional paranoid disorder: a forgotten syndrome.
    Jordan HW; Farmer MW
    J Natl Med Assoc; 1989 Sep; 81(9):950-2. PubMed ID: 2570877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [CLINICAL EXPERIENCES WITH THE TREATMENT OF DEPRESSION WITH TRIMEPROPRIMIN].
    VENCOVSKY E; PETEROVA E; SEDIVEC V; BAUDIS P
    Cesk Psychiatr; 1963 Oct; 59():338-9. PubMed ID: 14111795
    [No Abstract]   [Full Text] [Related]  

  • 51. Postpsychotic depression in schizophrenia patients.
    Kohler CG; Lallart EA
    Curr Psychiatry Rep; 2002 Aug; 4(4):273-8. PubMed ID: 12126595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Catamnestic studies on patients with various forms of schizophrenia who had been hospitalized from 1958-1965].
    Krzyzowski J
    Neurol Neurochir Psychiatr Pol; 1966 Jun; 16(6):685-91. PubMed ID: 5947706
    [No Abstract]   [Full Text] [Related]  

  • 53. [Dosage and comparative costs in psychopharmacotherapy].
    Gentil Filho V; de Lucia R
    AMB Rev Assoc Med Bras; 1979 Jul; 25(7):239-42. PubMed ID: 317680
    [No Abstract]   [Full Text] [Related]  

  • 54. The myth of involutional melancholia.
    Weissman MM
    JAMA; 1979 Aug 24-31; 242(8):742-4. PubMed ID: 459064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Investigation of the effectiveness of various antidepressive agents in endogenous melancholias as a function of the clinical picture].
    VANDIERENDONCK R
    Acta Neurol Psychiatr Belg; 1962 Jun; 62():702-12. PubMed ID: 13996221
    [No Abstract]   [Full Text] [Related]  

  • 56. [The correction of the metabolic and microcirculatory disorders in patients with atherosclerotic and involutional depressions].
    Vesel'skiĭ ISh; Pliushko AD
    Lik Sprava; 1995; (1-2):70-3. PubMed ID: 7483552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [METHODS FOR EVALUATING ANTIDEPRESSIVE SUBSTANCES WITH SPECIAL REFERENCE TO MONOCHLORO-IMIPRAMINE G34586].
    BRANDNER M
    Schweiz Arch Neurol Neurochir Psychiatr; 1964; 93():137-49. PubMed ID: 14127218
    [No Abstract]   [Full Text] [Related]  

  • 58. [An increase in the efficacy of psychopharmacotherapy of late-onset depressions: combination and substitution of antidepressants].
    Ivanets NN; Kinkulkina MA; Avdeeva TI; Tikhonova YG; Luk'ianova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):43-51. PubMed ID: 27240180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies on long-stay schizophrenic in-patients. 3. A cross-section (author's transl)].
    Hartmann W
    Arch Psychiatr Nervenkr (1970); 1973 Oct; 217(4):361-76. PubMed ID: 4769592
    [No Abstract]   [Full Text] [Related]  

  • 60. An investigation of the postpsychotic depressive syndrome.
    McGlashan TH; Carpenter WT
    Am J Psychiatry; 1976 Jan; 133(1):14-9. PubMed ID: 1247119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.